FBXO42: A Drug Target / Disease Biomarker (G54455)

Target Name: FBXO42

NCBI ID: G54455

FBXO42

FBXO42: A Drug Target / Disease Biomarker

FBXO42 is a protein that is expressed in various tissues throughout the body. It is a member of the superfamily of proteins known as the F-type ATPases, which are a group of transmembrane proteins that are involved in a wide range of cellular processes, including metabolism, ion transport, and signaling.

One of the unique features of FBXO42 is its ability to interact with small molecules, such as drugs, toxins, and other substances that are present in the body. This interaction allows FBXO42 to play a critical role in the regulation of a wide range of cellular processes, including the transport of oxygen and nutrients, the elimination of waste products, and the regulation of cell signaling pathways.

FBXO42 is also known for its role in the regulation of cell growth and differentiation. It has been shown to play a positive role in the development and maintenance of tissues and organs, and is often used in the treatment of diseases that involve these processes, such as cancer.

In addition to its role in cell signaling and growth, FBXO42 is also involved in the regulation of inflammation. It has been shown to play a negative role in the production and response to inflammation, which can lead to a wide range of diseases, including heart disease, autoimmune disorders, and chronic inflammatory diseases.

FBXO42 is also a potential drug target for a variety of diseases. For example, it has been shown to be involved in the regulation of cell signaling pathways that are involved in a wide range of diseases, including cancer, heart disease, and neurological disorders. It is also thought to be involved in the regulation of pain perception, which can lead to the development of chronic pain conditions.

In conclusion, FBXO42 is a protein that is involved in a wide range of cellular processes throughout the body. Its ability to interact with small molecules and its role in the regulation of cell signaling pathways, growth, and inflammation make it a promising target for the development of new drugs for a variety of diseases. Further research is needed to fully understand the role of FBXO42 in these processes and to develop effective treatments.

Protein Name: F-box Protein 42

Functions: Substrate-recognition component of some SCF (SKP1-CUL1-F-box protein)-type E3 ubiquitin ligase complex. Specifically recognizes p53/TP53, promoting its ubiquitination and degradation

The "FBXO42 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FBXO42 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets